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Abstract
Background: Rheumatoid arthritis (RA) is associated with abnormal liver tests, and
the medications used for RA are often hepatotoxic. Therefore, this study aimed to
investigate an association between pro-inflammatory and anti-inflammatory cytokines
and liver function tests in RA patients.
Methods: In this descriptive cross-sectional study, 88 RA patients were included,
84 of them were women and 4 men, aged 21–81 years. Serum interleukin-10 (IL-10),
interleukin-17 (IL-17), Osteopontin (OPN) were measured and liver function tests were
conducted.
Results: The frequency of RAwas higher among adults aged>41 years (72 [81.8%]) than
young adults aged ≤41 years (16 [18.2%]). RA was more common in women (84 [95.5%])
than in men (4 [4.5%]) – approximately 21:1-fold. Young adults had higher abnormal
IL-10 than adult RA patients (OR = 3.72, p-value 0.044). Abnormal IL-17 (OR = 5.67,
p-value 0.034) was found to be increased in young-adult RA patients. No association
was observed between age and OPN and between the duration of disease and IL-10,
IL-17, and OPN. Similarly, no association was noted between the types of treatment
and IL-10, IL-17, and OPN, nor between IL-10, IL-17, OPN and liver parameters (AST, ALT,
ALP, ALB, TP, and GGT).
Conclusion: Pro-inflammatory and anti-inflammatory cytokines are not associated with
abnormal liver functions, as has been demonstrated in RA patients.
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1. Introduction
Rheumatoid arthritis (RA) is a common autoimmune inflammatory disease. Although
the prevalence of RA is lower globally (0.5–1%), it is associated with socioeconomic
burden and higher risk of mortality rate [1]. Recent studies have demonstrated that
the treatments used for RA improved outcome, and also accounts as a risk for hepatic
complications [2]. The adverse effects of RA treatments include asymptomatic elevations
of liver enzyme, fibrosis, and sometimes fatal hepatic necrosis [3]. On the other hand,
liver disorders have been noted in untreated RA patients [4].
Increasing amounts of interleukin-10 (IL-10), a potent anti-inflammatory cytokine [5],
can be detected in the synovium of RA patients. Additionally, considering that the activity
of RA cannot be attenuated by IL-10 administration [6], many researchers suggest that
IL-10 plays an important role in chronic liver diseases [7]. Interleukin-17 (IL-17), a pro-
inflammatory cytokine, is upregulated in many autoimmune diseases such as RA; high
levels of IL-17 have been reported to be produced in different samples of RA [8, 9].
Some investigators suggest that IL-17 plays a key role in many liver diseases and is
also associated with the progress of the disease [10–12]. Osteopontin (OPN) is a pro-
inflammatory cytokine that induces RA [13–15], and included in many liver diseases,
despite its role in liver problems are still controversial [16]. Therefore, this study was
carried out to find out the association between pro-inflammatory, anti-inflammatory
cytokines and liver function tests among RA patients.
2. Materials and Methods
This descriptive cross-sectional hospital-based study was conducted on 88 RA patients
who were clinically diagnosed according to the criteria of the American College of
Rheumatology (ACR) 1987 and were examined at the common RA clinics in Khartoum
State (military, Alamal hospital, and Zain clinic). All patients received treatment; the
demographic data, type of treatment, and duration of disease for each patient were
recorded – 4 men and 84 women aged 28–90 years. Non-Sudanese patients with
RA and those with unclear diagnosis were excluded. Serum from each subject were
centrifuged at 3000 g for 10 min after clotting for 30 min at room temperature and
stored at –40°C until analysis. All samples were investigated for OPN, IL-17, and IL-
10 by sandwich enzyme-linked immune sorbent assay (ELISA) (ELISA Development;
Thermo Fisher scientific Systems, USA) according to the manufacturer’s instructions. In
addition, liver functions tests (TP, Albumin, AST, ALT, GGT, and ALP) were done using
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fully automated Mindray chemistry analyzer (BS 200). Data were statistically analyzed
by statistical software package, version 16. Results were expressed as numbers and
percentages. Chi-square test was used to determine the level of significance (P-value
of 0.05 was considered to be statistically significant).
3. Results
RA is more common in adults (72 [81.8%]) than young adults (16 [18.2%]), the frequency of
RA was found to be higher in women (84 [95.5%]) than in men (4 [4.5%]). Moreover, 52
(59.1%) patients were receiving steroids while 36 (40.9%) were on non-steroid treatment.
The duration of disease for 62 (70.5%) patients was ≤6 years and for 26 (29.5%) was >6
years. Abnormal IL-10 was found in 63 (71.6%) patients, while 25 (28.4%) had a normal
percentage. The results of characteristic data show that while 80 (91%) RA patients had
normal IL-17, 8 (9%) had abnormal. Normal OPN was observed in 76 (86.4%) RA patients
and abnormal OPN in 12 (13.6%) (Table 1). Chi-square analysis revealed that young adults
group had a higher abnormal IL-10 than adult RA patients (OR = 3.72, p-value 0.044).
Also, abnormal IL-17 (OR = 5.67, p-value 0.034) was found to be increased in young
adult RA patients while no association was seen between age and OPN (OR = 2.67,
p-value 0.144; Table 2). Furthermore, no association was reported between the duration
of the disease and IL-10, IL-17, and OPN with p-values 0.410, 0.176, and 0.502 and OR
0.77, 0.37, and 1.30, respectively (Table 3). Similarly, no association could be derived
between the types of treatment and IL-10, IL-17, and OPN with p-value 0.246, 0.286, and
0.351 and OR 1.53, 2.21, and 0.65, respectively (Table 4). Pearson’s correlation analysis
revealed that there were no association between IL-10, IL-17, OPN and liver parameters
(AST, ALT, ALP, ALB, TP, and GGT; Table 5).
4. Discussion
Abnormal liver functions were observed in RA patients. The researchers further
attributed the abnormality to immune aggregations and others justified it by drugs
toxicity. Accordingly, this study was carried out to assess whether the pro-inflammatory
or anti-inflammatory cytokines are associated with liver functions in RA patients.
The current study revealed that there is no association between interleukins and liver
function tests. In fact, abnormal liver tests were noted in patients with RA [17]. Concurrent
with many previous studies, the frequency of RA is higher in elderly subjects [18, 19]. A
possible explanation might be that the protective mechanisms in elderly population are
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TABLE 2: Association between interleukins IL10, IL17, OPN and age groups.





Abnormal 14 (23.0%) 47 (77.0%) 3.72 (0.78–17.7) 0.04
Normal 2 (7.4%) 25 (92.6%)
IL-17
Abnormal 2 (40.0%) 6 (60.0%) 5.67 (1.24–25.7) 0.03
Normal 12 (15.0%) 68 (85.0%)
OPN
Abnormal 4 (33.3%) 8 (66.7%) 2.67 (0.69–10.2) 0.14
Normal 12 (15.8%) 64 (84.2%)
decreased, resulting in decreased immunotolerance and decreased cytokines synthesis
and T cells proliferation [20]. The demographic data indicated that the prevalence of RA
was found to be 21-fold higher in women than in men. In contrast to a previous study
in Sudan, the female-to-male ratio was 9:1 [21]. Since the change in sex hormones after
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TABLE 3: Association between interleukins IL10, IL17, OPN and duration of RA.





Abnormal 42 (68.9%) 19 (31.1%) 0.77 (0.28–2.13) 0.41
Normal 20 (74.1%) 7 (25.9%)
IL-17
Abnormal 4 (50.0%) 4 (50.0%) 0.37 (0.08–1.65) 0.17
Normal 58 (72.5%) 22 (27.5%)
OPN
Abnormal 9 (75.0%) 3 (25.0%) 1.30 (0.32–5.25) 0.50
Normal 53 (69.7%) 23 (30.3%)
TABLE 4: Association between interleukins IL10, IL17, OPN and types of treatment.





Abnormal 38 (62.3%) 23 (37.7%) 1.53 (0.61–3.83) 0.24
Normal 14 (51.9%) 13 (48.1%)
IL-17
Abnormal 6 (75.0%) 2 (25.0%) 2.21 (0.42–11.6) 0.28
Normal 46 (57.5%) 34 (42.5%)
OPN
Abnormal 6 (50.0%) 6 (50.0%) 0.65 (0.19–2.21) 0.35
Normal 46 (60.5%) 30 (39.5%)
puberty is associated with high prevalence of RA in women, a woman’s immune system
is potentially more reactive than that of a man. The current study reports that young
adults are more likely to have abnormal IL-10 and IL-17. However, these results disagree
with previous studies [22, 23]. No association was found between age and OPN level.
Concurrent with this finding, a relationship between age and OPN has been previously
reported [24]. Similar to other results, no associations between IL10, IL17, OPN levels and
the duration of disease have been demonstrated [22, 23, 25]. Despite reducing IL-17
after the use of steroids therapy, IL-10 was increased [26]. The present study revealed
no associations between IL-10, IL-17, OPN levels and the types of treatment. It has
become clear that steroids directly modulate the pro-inflammatory cytokine or suppress
cytokines-producing cells [26, 27].
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TABLE 5: Association between cytokines and liver function parameters (Pearson’s correlation results).
Parameters P-value R2



















The data of present study shows that women are at a higher risk to have RA. Moreover,
young adult RA patients are more likely to have abnormal IL-10 and IL-17. Furthermore,
pro-inflammatory and anti-inflammatory cytokines are not associated with abnormal liver
functions as has been demonstrated in RA patients.
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